KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eqt (EQT) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Eqt (EQT) over the last 16 years, with Q3 2025 value amounting to $235.7 million.

  • Eqt's Cash & Equivalents rose 16493.14% to $235.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $235.7 million, marking a year-over-year increase of 16493.14%. This contributed to the annual value of $202.1 million for FY2024, which is 14956.84% up from last year.
  • According to the latest figures from Q3 2025, Eqt's Cash & Equivalents is $235.7 million, which was up 16493.14% from $555.5 million recorded in Q2 2025.
  • In the past 5 years, Eqt's Cash & Equivalents ranged from a high of $2.1 billion in Q1 2023 and a low of $16.9 million during Q1 2022
  • For the 5-year period, Eqt's Cash & Equivalents averaged around $402.4 million, with its median value being $114.0 million (2021).
  • Per our database at Business Quant, Eqt's Cash & Equivalents surged by 1247767.4% in 2023 and then plummeted by 9753.4% in 2024.
  • Eqt's Cash & Equivalents (Quarter) stood at $114.0 million in 2021, then soared by 1179.93% to $1.5 billion in 2022, then tumbled by 94.45% to $81.0 million in 2023, then soared by 149.57% to $202.1 million in 2024, then increased by 16.65% to $235.7 million in 2025.
  • Its Cash & Equivalents was $235.7 million in Q3 2025, compared to $555.5 million in Q2 2025 and $281.8 million in Q1 2025.